Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10156814 | Clinica Chimica Acta | 2018 | 24 Pages |
Abstract
DAMPA crystalluria was identified by Orbitrap⢠HRMS in a patient treated with CPDG2 after HDMTX nephrotoxicity. This case reinforces the need to implement adequate measures to prevent nephrotoxicity. In cases of HDMTX-induced nephrotoxicity, urine sediment analysis should be requested.
Keywords
AKICMIAMTXHRMSGC–MSLC-MS/MSacute kidney injuryChemiluminescent microparticle immunoassayhigh-dose methotrexateWorld Health Organizationgas chromatography–mass spectrometryhigh-resolution mass spectrometryFT-IRgranulocyte colony-stimulating factorG-CSFFourier-transform infraredMethotrexateSEMScanning electron microscopyNephrotoxicityHaemodialysisliquid chromatography–tandem mass spectrometryCrystalluriaWHO
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Francisco Berga, Pablo Luna, Clara Martorell, Juan Rey, Isabel Gomila, Sandra Gimenez, Antonia Costa-Bauza, Miguel Ángel Elorza, Iolanda Sánchez, Félix Grases, Bernardino Barceló,